Cinryze C1-inhibitor
C1-esterase inhibitor concentrateCinryze
As of December 2018, Sanquin has transferred the marketing and distribution rights of Cinryze for the Dutch, Belgian, Finnish and Turkish markets to Takeda.
Contact information
-
Contact information
For further details, please contact:
The Netherlands: Medical Lead: Egbert de Groot, tel. +31 (0) 6 52 57 91 65
Finland: Kaisa Elomaa, Medical Affairs Lead – kaisa.elomaa@shire.com
Mobile: +358 40 730 4289
Belgium: Ann Ruttens – +32 (0) 475 32 53 91 – aruttens-c@shire.com
Product characteristics
Contact our Sales Department